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Strengths and limitations of this study
 ► Strengths of the study include, first, the consider-
able expertise, methodological experience and skills 
that result from having a multinational and multidis-
ciplinary study team that also includes a patient’s 
representative.
 ► Second, the search will be broad based, use a sensi-
tive rather than a specific strategy and cover a wide 
range of databases, terms and search strategies (eg, 
forward citation tracking).
 ► Third, selection criteria will also be broad (ie, both 
qualitative and quantitative studies will be consid-
ered) and no restrictions will be placed on setting or 
language of publication.
 ► The main study limitation is poor indexing of articles 
and the lack of, or non-standardised definition, of 
‘patient preferences’ (eg, expressed as satisfaction, 
experience or perspectives).
 ► The planned evidence map is expected to help re-
searchers identify clusters and gaps in evidence on 
preferences of older patients with multimorbidity.
AbStrACt
Introduction Interaction of conditions and treatments, 
complicated care needs and substantial treatment burden 
make patient–physician encounters involving multimorbid 
older patients highly complex. To optimally integrate 
patients’ preferences, define and prioritise realistic 
treatment goals and individualise care, a patient-centred 
approach is recommended. However, the preferences 
of older patients, who are especially vulnerable and 
frequently multimorbid, have not been systematically 
investigated with regard to their health status. The purpose 
of this evidence map is to explore current research 
addressing health-related preferences of older patients 
with multimorbidity, and to identify the knowledge clusters 
and research gaps.
Methods and analysis To identify relevant research, 
we will conduct searches in the electronic databases 
MEDLINE, EMBASE, PsycINFO, PSYNDEX, CINAHL, Social 
Science Citation Index, Social Science Citation Index 
Expanded and the Cochrane library from their inception. 
We will check reference lists of relevant articles and carry 
out cited reference research (forward citation tracking). 
Two independent reviewers will screen titles and abstracts, 
check full texts for eligibility and extract the data. Any 
disagreement will be resolved and consensus reached with 
the help of a third reviewer. We will include both qualitative 
and quantitative studies, and address preferences from 
the patients’ perspectives in a multimorbid population 
of 60 years or older. There will be no restrictions on the 
publication language. Data extraction tables will present 
study and patient characteristics, aim of study, methods 
used to identify preferences and outcomes (ie, type of 
preferences). We will summarise the data using tables and 
figures (ie, bubble plot) to present the research landscape 
and to describe clusters and gaps.
Ethics and dissemination Due to the nature of the 
proposed evidence map, ethics approval will not be 
required. Results from our research will be disseminated 
by means of specifically prepared materials for patients, at 
relevant (inter)national conferences and via publication in 
peer-reviewed journals.
IntroduCtIon
Multimorbidity is defined as the co-occur-
rence of two or more acute or chronic diseases 
and medical conditions in one person.1 
The prevalence of multimorbidity increases 
significantly with age, rising from about 50% 
at the age of 60 years to more than 80% at the 
age of 80, although the estimates vary widely 
depending on the employed definition of 
multimorbidity.2–7 Interaction of conditions 
and treatments, complicated care needs and 
substantial treatment burden make patient–
physician encounters involving multimorbid 
older patients highly complex, and the clin-
ical management of these patients extremely 
challenging.8–10
Although interventions to improve rele-
vant outcomes in older patients with multi-
morbidity still lack high-quality evidence,11 12 
existing principles,13 clinical practice guide-
lines,14 recommendations for research9 and 
care models,15 all recommend a patient-cen-
tred approach that takes patient preferences 
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into consideration. Multimorbidity can be associated with 
overwhelming management burden, which makes it neces-
sary for physicians and patients to prioritise treatment 
plans by considering both the reduction of symptoms and 
the patients’ quality of life.16 17 As every treatment option 
consists of a specific combination of benefits, harms and 
burden, it is important that physicians understand the 
need to take older patients’ preferences and priorities 
into account in the decision-making process. Tailoring 
treatments to each individual older patient’s needs and 
preferences is likely to improve adherence to self-man-
agement interventions and medication.18
The GRADE working group defines preferences as 
choices that patients make when ‘considering the poten-
tial benefits, harms, costs, limitations and inconveniences 
of the management options in relation to one another’.19 
Overall, preferences include patients’ beliefs, expec-
tations, desires, perspectives and goals.19 Certain pref-
erences, such as the avoidance of pain, are stable and 
well articulated by patients. However, most preferences 
relating to the medical decision-making process have to 
be broken down into their individual components, as the 
patient is often not familiar with them. For example, the 
potential benefits and harms of a new drug treatment 
have to be taken into consideration and weighed against 
each other and across diseases, especially in older patients 
with multimorbidity. The elucidation and construction of 
preferences is a complex process that several disciplines 
have investigated from different perspectives.20–23
Healthcare decision-making in multimorbidity requires 
that health problems are prioritised in terms of desired 
versus undesired outcomes—a situation that patients 
often have no experience with.24 Clinical decision 
elements may be unfamiliar to them, and the available 
choices may present a conflict in that one goal can only 
be achieved by forgoing another.21 Moreover, multimor-
bidity is often characterised by a state of shifting priorities 
in self-management that can change from day to day.25 
Hence, most healthcare-related preferences must be 
constructed during a process of elicitation that is part of 
the decision-making process.21
Although several tools have been developed to assess 
multimorbid patients’ preferences (eg, for different treat-
ment options or outcomes) in terms of the prioritisation 
of their health-related goals,26 no structured attempt has 
yet been made to summarise the current state of research 
on healthcare-related preferences in this patient popu-
lation. However, the broad nature of this topic requires 
that existing evidence is mapped out, that is, a system-
atic search of existing knowledge in the field should 
be conducted to identify gaps and/or future research 
needs.27
In this article, we report the protocol of an evidence 
map to: (1) systematically identify and describe key char-
acteristics of research on health-related preferences 
of older patients with multimorbidity, (2) display the 
existing research landscape in visual formats, (3) identify 
evidence clusters to guide subsequent knowledge synthesis 
(systematic reviews and meta-analysis) and (4) identify 
evidence gaps to inform patients, clinicians, researchers, 
policy-makers and funding agencies, and to help identify 
future research priorities. This work will provide us with a 
thorough overview of research on the health-related pref-
erences of older patients with multimorbidity.
MEthodS And AnAlySIS
Evidence mapping is an innovative method of synthesising 
evidence that is particularly useful when the research 
question is too broad to permit a ‘traditional’ systematic 
review to be performed. Evidence maps have recently 
been recommended by the Agency for Healthcare 
Research and Quality’s Evidence-based Practice Center 
program28 as a first step towards systematically mapping 
existing research (clusters and gaps in evidence) that 
can help answer broad-based questions. They usually use 
visual formats (eg, bubble plots) to analyse and present 
results.29
The aim of the evidence maps is to ‘collate, describe 
and catalogue’ knowledge of a broad subject area.27 30 
Evidence maps are particularly effective when research 
questions are wide-ranging because they explore rather 
than summarise evidence. Consequently, the evidence 
maps do not include meta-analysis or compare the 
strength of evidence between studies but chart concepts, 
themes and the amount and type of evidence available.
The present protocol will follow, where applicable, the 
‘Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Extension for Scoping Reviews’ checklist31 
(see online additional file 1).
Following the framework originally establish by Arksey 
and O’Malley,32 refined by Levac et al33 and further devel-
oped by the Joanna Briggs Institute,34 six steps will be 
used to create the evidence map: (1) identifying a broad 
clinical question, (2) identifying relevant studies, (3) 
study selection, (4) charting the data, (5) reporting the 
results and (6) consultation.
Step 1: identifying a broad clinical question
A pilot test of an evidence map for our research ques-
tion (published elsewhere) was performed as part of a 
collaboration between the Institute of General Practice 
at Johann Wolfgang Goethe University (Frankfurt) and 
the Institute for Evidence in Medicine (for Cochrane 
Germany Foundation), Freiburg. It showed the feasibility 
of the mapping approach and areas for improvement, 
thus helping to refine the research question and the 
methods to be used.
We established a multidisciplinary research team of 
11 experts—some of whom had more than one area 
of expertise—from five countries (Australia, Canada, 
Germany, Spain and The Netherlands). In addition to 
a patient representative (one) the professionals repre-
sented primary care (two), internal medicine (one), geri-
atrics (one), cognitive psychology (one), public health 
and health services research (two), methodology (three), 
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Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
 ► Qualitative and quantitative studies addressing health-related 
preferences (priorities, goal oriented, goal attainment, shared 
decision-making, patient centred, patient oriented, ‘satisfaction’) 
from the patient’s perspective.
 ► Age: average age of 60 or older, geriatric patients, elderly 
patients.
 ► Polypharmacy: with or without polypharmacy.
 ► Multimorbidity: comorbidity, multiple chronic conditions.
 ► No restrictions: we will not apply any restrictions to the 
geographical location, healthcare context, country and 
publication language of the study.
 ► Case reports.
 ► Narrative reviews.
 ► Editorials.
 ► Studies investigating preferences for or against interventions 
that are not generally available or only legal in limited 
contexts (eg, euthanasia).
 ► Studies addressing only preferences of caregivers and 
healthcare professionals.
shared decision-making (one), epidemiology (one) and 
knowledge translation (one).
At the project kick-off meeting in April 2018, all 
members of the multidisciplinary research team contrib-
uted to the definition of the scope of the evidence map. 
Based on the results of previous exploratory research, we 
defined the following question to be addressed by our 
evidence map: What specific health-related preferences 
of older patients with multimorbidity are described in the 
available literature?
Step 2: identifying relevant studies
In order to identify relevant published studies, we will 
conduct a literature search in the following electronic 
databases: MEDLINE (1946 to 2018) via Wolters Kluw-
er’s search interface Ovid (indexed and non-indexed 
databases), CINAHL (1981 to 2018), PsycINFO (1800s 
to 2018) and PSYNDEX via EBSCOhost, Science Citation 
Index Expanded (1945 to 2018) and Social Science Cita-
tion index (1956 to 2018) via Clarivate Analytics’ Web 
of Science and EMBASE (1988 to 2018) via Ovid, and 
Cochrane Database (CENTRAL, TRIALS). We will check 
the reference lists of included articles (backward citation 
tracking) and carry out forward citation tracking using 
the Web of Science Core Collection. Additionally, we will 
search for related articles in PubMed. Authors of confer-
ence proceedings that have not published a full set of 
results will be contacted. Secondary research (ie, system-
atic reviews, synthesis of qualitative studies and scoping 
reviews) studies on related topics will be reviewed and 
references will be checked for possible inclusion in the 
evidence map. We will also search for ongoing trials in 
ClinicalTrials. gov and WHO register.
We followed the recommendations of PRESS Peer 
Review of Electronic Search Strategies and developed 
the final search strategy in collaboration with an expert 
medical sciences librarian.35
The full electronic search strategy for the MEDLINE 
database is provided in online additional file 2.
Based on the results of pilot testing, we agreed with all 
collaborative partners on the following eligibility criteria 
for the evidence map during the kick-off meeting in April 
2018 (see table 1):
Participants/population
Older patients (mean and/or median age ≥60 years) 
with multimorbidity (two or more simultaneous acute or 
chronic conditions1) of any type will be considered.
Outcomes
Our phenomena of interest (outcomes) will be: (1) pref-
erences related to the organisation of healthcare, (2) 
preferences for specific information, communication or 
involvement in a shared decision-making process, (3) 
preferences relating to desired, undesired and competing 
outcomes (in terms of safety and effectiveness), (4) prior-
itisation of health problems or conditions, (5) screening 
or diagnostic procedure preferences and (6) treatment 
preferences. The classification of the outcomes will be 
discussed and consecutively adapted, depending on the 
literature findings. This classification will further allow 
content analysis and the establishment of research clus-
ters and gaps.
Study setting
We will not apply any restriction to the geographical loca-
tion of the study or the language of publication, and we 
will include studies conducted in any setting, that is, any 
healthcare context in any country (including low-income 
and middle-income countries).
Study design
We will include qualitative and quantitative studies that 
address the phenomena of interest defined above from 
the patients’ perspectives.
We will exclude case reports, narrative reviews and 
editorials. We will leave out studies investigating prefer-
ences for or against interventions of limited availability 
or whose legal status is unclear (eg, euthanasia, which is 
neither legal nor available in most Western countries). 
Studies addressing only the preferences of caregivers, 
family or medical and/or other professionals will not be 
considered.
Step 3: study selection
Bibliographic details of all identified references will 
first be uploaded to EndNote and then converted into 
Covidence, which will automatically detect duplicate 
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Table 2 Data extraction framework
Bibliometrics Description Coding
First author, year of 
publication
Study characteristics Publication type Research article, conference, thesis, study protocol
Study type Primary or secondary research
Language For example, English
Geographical location Country, region, city
Study setting Hospital, general practice, nursing home, other
Study method Observational (ie, qualitative, quantitative, mixed-methods) or 
interventional study
Patient characteristics Definition of multimorbidity (Authors’ description)
No of patients Study sample
Age (Years)
Sex (% females)
Methods of data collection Type of data collection Interview, semistructured interview, survey, focus group, 
questionnaire (authors’ description)
Method of eliciting patients’ 
preferences
Tool definition (authors’ description)
Outcome Definition of patients’ preferences and 
priorities
(Authors’ definition)
  Type of patient’s preference assessed (Reviewers’ definition)
Study aim (Authors’ description)
Results/conclusions (Authors’ description)
documents. Two reviewers (AIG, JN) will independently 
screen titles and abstracts and will independently check 
full texts of the included articles for eligibility. Any 
disagreement will be resolved and consensus reached 
with the help of a third reviewer (CS). Before screening, 
a stepwise calibration exercise will be performed on 
a sample of 50 studies, with the aim of achieving 80% 
agreement between the two reviewers. In case 80% agree-
ment is not reached, our inclusion and exclusion criteria 
will be refined to reach this cut-off (eg, defined more 
stringently). Refined criteria will be calibrated on a new 
sample of 50 studies and repeated until this threshold is 
reached. We will report any changes to the inclusion and 
exclusion criteria that result from the calibration exercise 
as deviations from the published protocol.
Step 4: charting the data
Data extraction tables will be created using Excel and 
will include, when available: study characteristics such as 
research type (study design/methodology) and setting 
(healthcare context, country of origin and study period); 
patient characteristics (sample size, age, sex and defini-
tion of multimorbidity); aim of study; characteristics of the 
preferences, such as methods used to elucidate patients’ 
preferences, framing and definition of preferences (eg, 
treatment preferences, diagnostic preferences, desired, 
undesired and competing outcome preferences—as 
guided by the above description of the phenomena of 
interest) and results (see table 2).
Following a calibration exercise on five full texts, two 
reviewers (AIG, JN or CS) will independently extract the 
data. To check the adequacy of the extracted information, 
the data extraction file will be shared with other authors 
(CM, JB, MvdA, TH and SES), and changes performed 
where necessary.
Step 5: reporting the results
We will summarise the data using tables and figures (ie, 
bubble plot) to present the evidence landscape and to 
elucidate clusters and gaps. For each year, we will identify 
the number of primary and secondary research studies, as 
well as conferences and doctoral theses, which describe 
patients’ preferences. We will describe the identified 
studies in terms of characteristics such as location, setting 
and study design (ie, observational—qualitative, quan-
titative or mixed-methods—or interventional studies), 
subpopulation according to age or multimorbidity 
pattern/severity if possible, and study objectives aggre-
gated according to research topic (ie, type of preference) 
(table 2).
Clustering of research topics will be performed by 
applying content analysis36 37 to summarise the types of 
preference described in the study. Based on coding by 
two independent reviewers (AIG, JN or CS), overarching 
copyright.
 o
n
 Septem
ber 9, 2019 at Bond University. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029724 on 3 September 2019. Downloaded from 
5González-González AI, et al. BMJ Open 2019;9:e029724. doi:10.1136/bmjopen-2019-029724
Open access
themes will be identified and aggregated. For this purpose, 
the results will be entered into the data extraction file, 
which will then be reviewed by the other researchers 
(CM, JB, MvdA, TH and SES). Categories for the analysis 
of the obtained data will be modified accordingly, along 
with the development of the evidence map, and agreed 
on after consultation with the research team.
Step 6: consultation
The development of the evidence map will follow an iter-
ative process and all members of the research team will 
be consulted during all steps of the project, including the 
identification of relevant literature, study selection and 
data extraction. In November 2018, we held a workshop 
to present the results of the preliminary search strategy 
and exploratory investigation, and to obtain feedback 
before conducting further searches and other activities. 
We discussed interim results, refined the methodology 
and agreed on the best formats for reporting our find-
ings. Cluster definitions of the identified research topics 
were discussed and agreed on by all authors. All neces-
sary changes were established before continuing with the 
development of the evidence map.
The present study started on 1 February 2018 and is 
scheduled to end on 31 October 2019.
Patient and public involvement
A patient representative (KR) from the Federal Joint 
Committee ‘Gemeinsamer Bundesausschuss (G-BA)’ will 
actively participate in all six steps required to create the 
evidence map. As a result of his work on the G-BA board 
of patients’ representatives, KR has considerable exper-
tise in evidence-based medicine in a healthcare context, 
and an understanding of the pivotal role of patients’ pref-
erences in the provision of effective healthcare. The G-BA 
constitutes the highest decision-making body for the joint 
self-administration of stakeholders in the German health 
service, and the statutory health insurance service cata-
logue for over 70 million insured individuals is based on 
its guidelines.
EthICS And dISSEMInAtIon
We prepare presentations to disseminate the study find-
ings to healthcare providers and patients, and at relevant 
national and international conferences, and we aim to 
publish the results of the study in peer-reviewed journals. 
We will provide recommendations for primary research 
that are based on the identified knowledge gaps, and 
recommendations for secondary research that are based 
on knowledge clusters.
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